Latest 3D Digital Venue News
May 11, 2021
2 minute read Global Medical Technologies Manila has officially closed its partnership deal with Metropolitan Medical Center to offer more imported diagnostic tests locally. Present during the contract signing are (from left): April Francisco, GMT trade marketing manager; Harmon Herman, GMT medical presales manager; Chill Orbegoso, GMT key accounts head; Dr. Sheryll Pua, MMC head of corporate planning and business development; Rebecca Uy-Tanganco, MMC procurement manager (head of Supply Chain Division); and Jean Azucena, MMC marketing head. AMID hesitation and worry of patients to have in person consultations with their attending physicians for fear of contracting the virus, Global Medical Technologies (GMT) Manila, a subsidiary of Romlas Health Group, it has pursued its partnership with the Metropolitan Medical Center (MMC) to offer a wide array of personalized diagnostic tests and medical services covering various health concerns, such as nutrition, gut health, allergy, cancer, mental health, and genetics. Through their collaborative efforts, MMC patients can avail of advanced testing solutions, including the Food Intolerance Test, which finds out the food causes behind symptoms like headaches, bloating, nausea; FABER (P-Friendly Allergen Nano-Bead Array), which finds out which substances the patient is allergic to with just one blood sample; the Organic Acids Test, which finds out if conditions like fatigue and autoimmune disorders are caused by metabolic processes; and Genomind, which finds out the best treatment for the patient’s mental and emotional disorder based on their genes. Other tests are targeted towards cancer such as Cellmax Life, which finds out a person’s hereditary cancer risk; and Onconomics, which finds out the best personalized treatment for a cancer patient. Most of these tests just take a simple blood or urine test to get comprehensive results. The diagnostic tests of GMT Manila are of great support to its Wellness Center, according to MCC Hospital Administrator Dr. Chester Tan. “Moving forward, I see these diagnostics tests as the future in the medical practice in the treatment of our clients with different medical conditions. They focus more on preventing diseases and having good health to begin with, instead of cure,” he said. With its alliance with MCC, GMT Manila is driven further to fulfill its thrust to better serve the patients of its partner-hospitals and other medical institutions by ensuring ample supply of diagnostic tests in these trying times. The ensuing pandemic, per GMT Manila Brand Manager Vanz Cruz, has resulted to hesitation of most non-Covid-19 patients to avoid face-to-face consultation with their doctors to avoid any possible Covid-19 infection. “The different non-communicable diseases we are serving with our diagnostics tests are still prevalent, but with challenges of medical check ups with the different specialists that uses our tests resulted to a decline in the demand, but we are focused still in helping our patients to have the best available test to help their doctors in the preparation of their treatments,” he told the Businessmirror in an interview through social media. GMT Manila distributes locally imported diagnostic tests from principal partners based in the United States, the United Kingdom, Austria, Switzerland and Italy. “We have challenges especially in the send out of the specimen because we get the services of commercial delivery services as they are affected by the current pandemic as well,” Cruz bared. “But with regards to the availability of the kits of the different tests we had an internal arrangement with our principals to have ample kits to serve all our customers and partners which we based on projections,” he said.